J. Safra Sarasin Holding AG Makes New Investment in Corteva, Inc. $CTVA

J. Safra Sarasin Holding AG acquired a new stake in Corteva, Inc. (NYSE:CTVA) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,215 shares of the company’s stock, valued at approximately $855,000.

A number of other institutional investors have also bought and sold shares of CTVA. Vanguard Group Inc. boosted its position in shares of Corteva by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after purchasing an additional 317,538 shares in the last quarter. State Street Corp grew its stake in Corteva by 3.7% in the 4th quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after purchasing an additional 1,290,071 shares during the period. Franklin Resources Inc. grew its holdings in Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after purchasing an additional 805,873 shares during the period. Harris Associates L P grew its stake in Corteva by 168.1% in the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after buying an additional 10,675,052 shares in the last quarter. Finally, Northern Trust Corp grew its holdings in Corteva by 5.0% during the 4th quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after buying an additional 562,550 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Trading Down 1.3%

NYSE CTVA opened at $84.91 on Wednesday. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $87.69. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $56.79 billion, a P/E ratio of 49.95, a P/E/G ratio of 2.63 and a beta of 0.56. The firm has a 50-day moving average price of $80.53 and a 200 day moving average price of $77.87.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s payout ratio is presently 42.35%.

Analysts Set New Price Targets

CTVA has been the topic of a number of research analyst reports. Citigroup increased their target price on Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. The Goldman Sachs Group lifted their price target on Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, April 14th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Corteva from $90.00 to $100.00 in a research note on Monday, May 11th. Berenberg Bank boosted their price target on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research note on Thursday, March 26th. Finally, Rothschild & Co Redburn lifted their target price on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Thirteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and a consensus price target of $88.95.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.